Across TCGA pan-cancer cohorts, CGA Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CGA data layer compared with 22 for mass-spec protein.
The strongest signal is observed in rectum adenocarcinoma (READ), where higher CGA Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CGA expression acts as an unfavorable survival marker.
READ and GBM are the cancer types where CGA Mutation most reproducibly stratifies survival.